May 2013 - Global Lifesciences Business in India- News & Updates


Top Highlights for May 2013:  (Please click on news title to view details)

 

  1. Smith & Nephew Acquires Indian Trauma Business for Rs. 380 crore.
  2. Goldman Sachs invests Rs.110 cr in Indian BPL Medical.
  3. Dr Reddy's of India grows at 20% to achieve revenues of Rs 116.3 billion
  4. India based Cadila Healthcare launches tablet in US for 176 million USD Migraine market
  5. India based Glenmark, Gets Approval From FDA For Migraine which is a 176 million USD market
  6. Indian Pharma Venus signs marketing deal for their antibiotic with South Korean Goodwills Co helping them to address 15% of the USD 300Mn antibiotic segment
  7. India pharmaceuticals to grow at a CARG of 14-17% over 2012-16.
  8. Switzerland based STMicroelectronics looks at India for tapping part of 15-20% growth (in next two years) in Asian medical devices market.
  9. "Indian vaccines are globally competitive. India produces 60 percent of the worlds vaccine and account for about 70 percent of the annual United Nations vaccine purchases.The current Indian vaccine market is estimated at around $900 million"
×
Twitter